Tag Archives: India

Traditional Knowledge and Genetic Resources: India Misses the Mark

2499660451_634e5f1235

India recently asked the global community for comments on its “Draft Guidelines for Processing of Patent Applications Relating to Traditional Knowledge and Biological Material.”  BIO was very active in their support of the goals of the Convention on Biological Diversity and “believes that a practical and workable Access and Benefit Sharing regime will benefit both the owner and the user of genetic resources and help countries to utilize their resources to develop their economies.”  BIO Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO India Hosts Biopharmaceutical Regulatory and Policy Roundtable

bio-india-btn

During last week’s BIO India International Conference, BIO, in partnership with the Association of Biotech-Led Enterprises (ABLE) and the Confederation of Indian Industries (CII) held a roundtable to discuss ways that U.S. and Indian industry can work together to facilitate the development of new biotechnology products and commercialization. Participants in the roundtable represented U.S. and Indian industry, academia, and government and shared their views on critical issues important to the development of the Indian biotechnology Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Jim Greenwood Shares his Thoughts on BIO India

Jim Greenwood

As a non-profit trade association that represents the biotech industry, BIO is pleased to bring the BIO International Conference back to India in an effort to further create and drive business development and collaborations between the US and Indian industry in all areas relating to biotechnology. The conference, which will be held in Mumbai this year on September 12-13, brings together global business and thought leaders in the various areas of biotechnology for partnering. For Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BioSpectrum Asia Survey Shows Promising Results for the Biosciences Industry

India2012_Thumbnail

BioSpectrum Asia recently completed a survey of close to 500 bioscience companies listed on different stock exchanges in both the Asia Pacific region (APAC) and in American stock exchanges, with total revenue of $139 billion (year end 2011) and market capitalization of $200 billion. The survey says of the top 20 companies in the region, comprising mostly of pharmaceutical, biotechnology and medical technology companies and focusing on R&D, manufacturing and marketing of life sciences products, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Novartis at India Supreme Court: Evergreening Myths and Patent Reality

Pine

Novartis will go before India’s Supreme Court on September 11, 2012 challenging the refusal by the Indian Patent Office to grant a patent on its cancer drug Glivec.  The Indian Patent Office rejected Novartis’ application under a provision in Indian law which is aimed at guarding against so called “patent evergreening.” BIO has written two posts deconstructing the myth of patent evergreening. 1.  Patent “Ever-Greening”: Novartis Confronts Patent Myth in India 2.  Patent Evergreening in Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,